NCT06912087 2025-12-02Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCCUniversity of ChicagoPhase 1 Recruiting36 enrolled
NCT00401323 2011-01-20Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaSanofiPhase 2/3 Completed568 enrolled